[Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 2]

Rev Esp Anestesiol Reanim. 2011 Apr;58(4):236-42. doi: 10.1016/s0034-9356(11)70046-9.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control*
  • Cerebral Angiography
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dioxanes / therapeutic use
  • Endothelin A Receptor Antagonists
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Intracranial Aneurysm / complications
  • Intracranial Aneurysm / surgery
  • Magnesium / therapeutic use
  • Male
  • Meta-Analysis as Topic
  • Middle Aged
  • Multicenter Studies as Topic
  • Neuroprotective Agents / therapeutic use
  • Pyridines / therapeutic use
  • Pyrimidines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / therapy
  • Sulfonamides / therapeutic use
  • Tetrazoles / therapeutic use
  • Vasospasm, Intracranial / diagnostic imaging
  • Vasospasm, Intracranial / etiology
  • Vasospasm, Intracranial / prevention & control

Substances

  • Dioxanes
  • Endothelin A Receptor Antagonists
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Neuroprotective Agents
  • Pyridines
  • Pyrimidines
  • Sulfonamides
  • Tetrazoles
  • clazosentan
  • Magnesium